Powerful solutions for Pre-Launch/Early-Stage Assets



Market Assessments
  • Comprehensive Literature searches for epi, market growth projections
  • Sizing Treatment Flows and Market Shares analysis using Big Data/ Claims/EMR/EHR/Lab etc.
  • Dynamic Patient Journey quantification and visualization
AI ML Use Case to Identify and Target Emerging Patients
ML solution predicted with 76% accuracy 3k new patients with a high likelihood of being prescribed the target brand, translating to $480M in potential revenue.
Read More
(5b) Case Study
Case Study Title
Excerpt content…
Read More
Brand Opportunity Assessments
  • Patient based Forecast Model to size opportunity and build scenarios for different share, access, promotional & market entry/competitor event options
  • Leverage Points Workshops to size & prioritize brand opportunities
  • Strategic Consulting & Analysis Support
(6a) Case Study
Case Study Title
Excerpt content…
Read More
(6b) Case Study
Case Study Title
Excerpt content…
Read More
Access Assessment
  • Assessment of Access environment in given therapy area
  • Payer Influence / Payer Mix Analyses
  • Time to Reimbursement for available therapies – Remit/PlanTrak and other data assets
  • Treatment shares by Payer /Plan using claims data
(7a) Case Study
Case Study Title
Excerpt content…
Read More
(7b) Case Study
Case Study Title
Excerpt content…
Read More
Clinical Trial Accelerator
  • IZE Trial Optimizer offering
  • Proactive field-based triggers to find appropriate patients
  • Proven to accelerate recruitment and time to market
  • Particularly relevant for difficult to recruit Rare Disease/ niche Indications
  • AI/ML predictive modelling, NLP analytics for translating medical notes
Expedite COVID 19 Trial Enrollment
Predicting COVID-19 surges at a county level for the next 30 days could ultimately pave the way for speedier trial enrollment
Read More
Accelerating Trial Enrollment via IZE Trial Accelerator
Harness the predictive power of AI ML & NLP to expedite clinical trial enrollment.
Read More